Daily low-dose aspirin can reduce colon cancer risk by 30%

09/16/2010 | Washington Post (tiered subscription model), The

A study published in the journal Gut found that people who took a single low-dose aspirin daily reduced their colon cancer risk 22% after one year and as much as 30% in five years. Researchers said patients taking other treatments in the class of nonsteroidal anti-inflammatory drugs also had a reduced risk of developing the disease.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI